HBC — Hofseth Biocare ASA Share News
0.000.00%
Last trade - 00:00- NOK513.85m
- NOK746.89m
- NOK256.34m
Brief: Hofseth Biocare expects to report Q3 revenues of about NOK 28 mln
Brief: Hofseth Biocare: Roger Hofseth new CEO in HBC
Brief: Hofseth Biocare to sell and lease contracts of properties
Brief: Hofseth Biocare Q4 operating loss narrows to NOK 18.5 million
Brief: Hofseth Biocare Q3 EBITDA loss widens to NOK 41.2 mln
Brief: Hofseth Biocare reports final results of Subsequent Offering
Brief: Hofseth Biocare receives patent in the European Union
Brief: Hofseth Biocare Q2 operating loss widens to NOK 47.5 million
Brief: Hofseth biocare announces equity issue of minimum NOK 165 mln
Brief: Hofseth Biocare: OmeGo patent notice of allowance in US and new study on ProGo
Brief: Hofseth Biocare cancels subsequent offering
Brief: Hofseth BioCare Q1 EBIT widening to NOK 25.5 million
Brief: Hofseth Biocare completes private placement of NOK 23.6 mln
Brief: Hofseth Biocare starts selling products in XXL
Brief: Arctic Seafood Group sells 6.2 mln shares in Hofseth Biocare
Brief: Christoph Baldegger buys 580,000 shares in Hofseth Biocare ASA
Brief: Hofseth Biocare Q4 operating revenue up at NOK 26.7 million, operating loss narrows
Brief: Hofseth Biocare: new study shows ProGo significantly reduces BMI
Brief: Hofseth Biocare: Roger Hofseth to serve as chairman until AGM in 2016